Tuberculosis research: Going forward with a powerful “Translational Systems Biology” approach
Received 8 December 2009; accepted 9 December 2009. published online 04 January 2010.
Summary
Due to the complexity of the immune response to a Mycobacterium tuberculosis infection, identifying new, effective therapies and vaccines to combat it has been a problematic issue. Although many advances have been made in understanding particular mechanisms involved, they have, to date, proved insufficient to provide real breakthroughs in this area of tuberculosis research. The term “Translational Systems Biology” has been formally proposed to describe the use of experimental findings combined with mathematical modeling and/or engineering principles to understand complex biological processes in an integrative fashion for the purpose of enhancing clinical practice. This opinion piece discusses the importance of using a Translational Systems Biology approach for tuberculosis research as a means by which to go forward with the potential for significant breakthroughs to occur.
aMathematical Biosciences Institute, The Ohio State University, Jennings Hall, 3rd Floor, 1735 Neil Ave, Columbus, OH 43210, USA
bCenter for Microbial Interface Biology, Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University, Biomedical Research Tower, 460 W 12th Ave, Room 1004, Columbus, OH 43210, USA
cDepartment of Mathematics, The Ohio State University, 236 Mathematics Building, 231 W Eighteenth Ave, Columbus, OH 43210, USA